P aradoxic acceleration of the ventricular rate is a well-known risk of drug therapy for rapid supraventricular arrhythmias with atrioventricular block. The classic example is seen in therapy with quinidine for atrial flutter. As quinidine slows the atrial rate and blocks the vagal effect on the atrioventricular node, the number of impulses reaching the atrioventricular node is reduced from a rate between 300 ( Fig 1A ) . Frequent early beats (Fig 1A) probably represent conducted supraventricular beats.
In two patients witb mpraventricular tachyarrhythmhs r r i t b a~v~M o c k , t b e r a p y~H d o c r i n c a n d a~e d e c r a t d t b e a t x i o v~# o c L r a n d c a a s e d paradoxic ~~n of the ventricplro &. A p p r i . t e t r t l t m c n t o f t h i S~~o f t b e r a p y w i t h a d m i m y t h i c drugs is reviewed.
P aradoxic acceleration of the ventricular rate is a well-known risk of drug therapy for rapid supraventricular arrhythmias with atrioventricular block. The classic example is seen in therapy with quinidine for atrial flutter. As quinidine slows the atrial rate and blocks the vagal effect on the atrioventricular node, the number of impulses reaching the atrioventricular node is reduced from a rate between 300 ( Fig 1A ) . Frequent early beats (Fig 1A) probably represent conducted supraventricular beats.
The diagnosis of digitalis-indud "premature ventricular beats" was made, and treatment was oriented towards their elimination, while the presence of the probable digitalisinduced paroxysnal atrial tachycardia with 2:l block was apparently deliberately ignored. Thus, 100 mg of lidocaine was given, foUowed by a drip infusion of 4 mg/min.
Shortly thereafter, bursts of rapid ventricular activity at a rate of 200 beats per minute appeared ( Fi lB), representing intennittent 1:l conduction of the rapid atrial rate.
Carotid pressure transiently reestablished atriwentricular block, and organized P-wave activity could be seen at the rate of 230/min in olle strip ( not shown) ; the ventricular rate r e m a i d about 95 to 100 beats per minute, with occasional bursts of U)O beats per minute ( Fig 2A ) . Ajmaline ( 25 mg ) was given i n t r a v e d y to abolish the persistent "premature ventricJarbeats,"aswellastodecreasethe rateof the atrial tachycardia. As the atrial rrrte slowed to 175 impulses per minute, the bursts of rapid ventricular rate became more These two cases demonstrate the electrophysiologic mechanisms which interact to produce the final ventricular rate in supraventricular arrhythmias. They also illustrate the potential pitfalls encountered during antiarrhythmic therapy when too much attention is directed toward ventricular premature beats and not enough to the rapid atrial rate which is associated with atrioventricular block. * can result from either slowing of the atrial rate, a decrease in the atrioventricular block, or both. The primary mechanism of quinidine-induced ventridar acceleration is the slowing of the atrial rate, but there is some evidence that a vagolytic effect on the atrioventricular node may also be partially responsible.lJ The present report demonstrates that the same acceleration of the ventricles can be produced by adminhation of lidocaine and ajmaline, and that therapy with lidomhe may be capable of enhancing atrioventricular conduction even when the atrioventricular node is presumably p m tected by digitalis. The bursts of rapid ventricular rate in the first patient became more frequent and finally changed to a seakrtned ventricular rate of 150 beats per minute under the influence of ajmaline. In the second patient, acceleration occurred just a few moments after administration of ajmaline. Ajmaline shares several properties with quinidine in its effects on cardiac fibers.6*7 It decreases the maximum rate of depolarization and the velocity of conduction in Purkinje's fibers,$ and Wellens and Durrer9 observed prolongation of the His-ventricle interval by ajmaline therapy in man. On the other hand, as with quinidine and procaine amide hydrochloride,"l . admmstration of ajmaline does not always lengthen the effective refractory period of the atrioventricular node.s It, thus, is predictable that ajmaline therapy, by slowing the velocity of conduction and the rate in the atrium without simultaneously increasing the effective refractory period of the atrioventricular node, can produce the same paradoxic acceleration of the ventricles as quinidine and lidocaine.
We concur with others2*' that lidocaine therapy should be used for the treatment of ventricular prema- 
